RENASANT CORP
For the period ended Dec 31, 2024. Filed Feb 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 26, 2025
RNST$40.14+1.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Assets | ||
| Cash and due from banks | $198,408 | $206,680 |
| Interest-bearing balances with banks | 893,624 | 594,671 |
| Cash and cash equivalents | 1,092,032 | 801,351 |
| Securities held to maturity (net of allowance for credit losses of $32 at both December 31, 2024 and 2023) (fair value of $1,002,544 and $1,121,830, respectively) | 1,126,112 | 1,221,464 |
| Securities available for sale, at fair value | 831,013 | 923,279 |
| Loans held for sale, at fair value | 246,171 | 179,756 |
| Loans held for investment, net of unearned income | 12,885,020 | 12,351,230 |
| Allowance for credit losses | (201,756) | (198,578) |
| Loans, net | 12,683,264 | 12,152,652 |
| Premises and equipment, net | 279,796 | 283,195 |
| Other real estate owned, net | 8,673 | 9,622 |
| Goodwill | 988,898 | 991,665 |
| Other intangible assets, net | 14,105 | 18,795 |
| Bank-owned life insurance | 391,810 | 382,584 |
| Mortgage servicing rights | 72,991 | 91,688 |
| Other assets | 300,003 | 304,484 |
| Total assets | $18,034,868 | $17,360,535 |
| Liabilities and shareholders’ equity | ||
| Liabilities | ||
| Deposits | ||
| Noninterest-bearing | $3,403,981 | $3,583,675 |
| Interest-bearing | 11,168,631 | 10,493,110 |
| Total deposits | 14,572,612 | 14,076,785 |
| Short-term borrowings | 108,018 | 307,577 |
| Long-term debt | 430,614 | 429,400 |
| Other liabilities | 245,306 | 249,390 |
| Total liabilities | 15,356,550 | 15,063,152 |
| Shareholders’ equity | ||
| Preferred stock, $0.01 par value – 5,000,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock, $5.00 par value – 150,000,000 shares authorized; 66,484,225 shares issued; 63,565,690 and 56,142,207 shares outstanding, respectively | 332,421 | 296,483 |
| Treasury stock, at cost, 2,918,535 and 3,154,518 shares, respectively | (97,196) | (105,249) |
| Additional paid-in capital | 1,491,847 | 1,308,281 |
| Retained earnings | 1,093,854 | 952,124 |
| Accumulated other comprehensive loss, net of taxes | (142,608) | (154,256) |
| Total shareholders’ equity | 2,678,318 | 2,297,383 |
| Total liabilities and shareholders’ equity | $18,034,868 | $17,360,535 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.